Curtis Champion
Internal Medicine · Forest Park, GANPI 1467524835
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 152 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by Lilly USA, LLC at 24.9% of the total. Reporting peaked in 2022 at $803 and has fallen 78.8% since, to $170 in 2025.
Across 152 payments — averaging $19.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$731
- GSK$372
- Sanofi-aventis U.S. LLC$237
- Novo Nordisk$173
- Vanda Pharmaceuticals Inc.$169
- Abbott$157
- plus $1K from 21 others
What the payments were for
- Food & beverage$2,937100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 39 | $731 |
| GSK | 18 | $372 |
| Sanofi-aventis U.S. LLC | 15 | $237 |
| Novo Nordisk | 10 | $173 |
| Vanda Pharmaceuticals Inc. | 8 | $169 |
| Abbott | 9 | $157 |
| Boehringer Ingelheim | 7 | $130 |
| Novartis | 7 | $128 |
| Bayer | 6 | $127 |
| Atricure, Inc. | 1 | $126 |
| AstraZeneca | 4 | $86 |
| Merck | 4 | $74 |
| Redhill Biopharma Inc. | 4 | $73 |
| EMD Serono, Inc. | 3 | $45 |
| Gilead | 2 | $43 |
| Pfizer | 2 | $40 |
| Dexcom, Inc. | 2 | $39 |
| Seqirus USA Inc | 2 | $31 |
| Shield Therapeutics Inc | 1 | $22 |
| Amarin Pharma, Inc. | 1 | $22 |
| Eisai Inc. | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Boston Scientific | 1 | $15 |
| Linus Health, Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,937 in reported general payments places this provider in the 80th percentile of 3,311 internal medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 124 | $167,256 |
| TrulicityDulaglutide | 30 | $73,618 |
| OzempicSemaglutide | 64 | $73,380 |
| EliquisApixaban | 47 | $59,248 |
| TradjentaLinagliptin | 42 | $59,248 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 76 | $58,618 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 53 | $46,092 |
| LinzessLinaclotide | 38 | $46,064 |
| FarxigaDapagliflozin Propanediol | 20 | $26,898 |
| MounjaroTirzepatide | 15 | $19,228 |
| JardianceEmpagliflozin | 19 | $16,084 |
| Diclofenac Sodium | 157 | $11,194 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 22 | $10,151 |
| Levemir FlexpenInsulin Detemir | 38 | $6,211 |
| SymbicortBudesonide/Formoterol Fumarate | 13 | $4,664 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia | $74 | $167,256124 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $731 | $92,84645 claims |
| Boehringer IngelheimTradjenta, Jardiance | $130 | $75,33161 claims |
| Novo NordiskOzempic | $173 | $73,38064 claims |
| PfizerEliquis | $40 | $59,24847 claims |
| GSKTrelegy Ellipta | $372 | $58,61876 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $237 | $46,09253 claims |
| AstraZenecaFarxiga, Symbicort | $86 | $31,56233 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,311 internal medicine providers in Georgia.
Other internal medicine in Forest Park
- Michael GibsonSmyrna$2.2M
- Eduard FatakhovAlpharetta$376K
- Tracey HenryAtlanta$305K
- Sharon TuckettVilla Rica$265K
- Ebon BourneMarietta$242K
- Jennifer WoehlerSavannah$207K
- Julian HutchinsGreensboro$201K
- Brian PearlmanDalton$199K
- Scott ParryAtlanta$162K
- Jennifer GilliganAtlanta$162K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.